Anorectal manifestations in systemic diseases.

[Anorectal manifestations in systemic diseases]. Rev Med Interne. 2019 Aug 07;: Authors: Egal A, London J, Lidove O, Atienza P, Etienney I Abstract Numerous systemic diseases (vasculitis, connective tissue disease or sarcoidosis) can display an involvement of the perianal skin, the rectum and/or the anus. Such knowledge is important in order to treat these complications specifically when possible. Lesions of the anorectum arising from systemic diseases can sometimes cause perforations in the peritoneal cavity (if concerning the higher portion of the rectum) and/or fistulization to the anal margin. Differential diagnosis, mostly infectious or inflammatory (Crohn's disease) must be ruled out in every case. Other systemic diseases can display specific manifestations as this is the case in scleroderma which can lead to anal incontinence. Despite the relative rarity of these manifestations, their ignorance would forbid global management of these complex diseases. It should thus be detected in each consultation and a regular follow-up must be provided with a proctologist and/or a gastroenterologist when needed. PMID: 31400822 [PubMed - as supplied by publisher]
Source: Revue de Medecine Interne - Category: Internal Medicine Tags: Rev Med Interne Source Type: research

Related Links:

Authors: Moon JR, Lee CK, Hong SN, Im JP, Ye BD, Cha JM, Jung SA, Lee KM, Park DI, Jeen YT, Park YS, Cheon JH, Kim H, Seo B, Kim Y, Kim HJ, MOSAIK study group of the Korean Association for the Study of Intestinal Diseases (KASID) Abstract Background/Aims: Limited data are available regarding psychosocial distress at the time of diagnosis of ulcerative colitis (UC). We investigated the psychosocial burden and factors related to poor health-related quality of life (HRQL) among patients newly diagnosed with moderate-to-severe UC who were affiliated with the nationwide prospective cohort study. Methods: Within the ...
Source: Gut and Liver - Category: Gastroenterology Tags: Gut Liver Source Type: research
In conclusion, turanose can attenuate colitis via regulatory effects on miRNA-21 expression and histone acetylation-related proinflammatory mediators. These findings also support further exploration of turanose as a potential therapeutic sugar substitute for patients with IBD.Graphical abstract
Source: Journal of Functional Foods - Category: Nutrition Source Type: research
This article uses a case study to explore the diagnosis of BD.
Source: The Nurse Practitioner - Category: Nursing Tags: Feature: CHRONIC INFLAMMATORY CONDITIONS: CE Connection Source Type: research
Authors: Feng Y, Wang P, Cui B PMID: 31530368 [PubMed - as supplied by publisher]
Source: Medicina Clinica - Category: General Medicine Tags: Med Clin (Barc) Source Type: research
Conditions:   Stress Urinary Incontinence;   Fecal Incontinence Interventions:   Drug: Citalopram 40mg;   Drug: Reboxetine 8 mg;   Drug: Placebo oral tablet Sponsor:   University Hospital Bispebjerg and Frederiksberg Recruiting
Source: - Category: Research Source Type: clinical trials
Condition:   Ulcerative Colitis Interventions:   Drug: LC51-0255;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Conclusions: Dry mouth, constipation, dysgeusia, loss of appetite, early satiety, and dysphagia are the most common (and possibly characteristic symptoms) related to the digestive system in people at the early and middle stages of PD. Being male is a risk factor for dysgeusia, dysphagia, early satiety, and constipation. PMID: 31531219 [PubMed]
Source: Parkinsons Disease - Category: Neurology Tags: Parkinsons Dis Source Type: research
No abstract available
Source: Acta Dermatovenerologica Croatica - Category: Dermatology Source Type: research
Authors: Af Björkesten CG, Jussila A, Kemppainen H, Hallinen T, Soini E, Mankinen P, Valgarðsson S, Veckman V, Nissinen R, Naessens D, Molander P Abstract Background and Aims: A retrospective non-interventional, multi-centre patient chart review study was conducted to investigate the association of faecal calprotectin (FC) 1 year (±2 months) after biological therapy initiation with composite event-free survival (CEFS) consisting of surgical procedures, corticosteroid initiation, treatment failure or dose increase in patients with Crohn's disease (CD). In addition, the correlations of F...
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
In this study, we aim to assess plasma and serum calprotectin measurements as biomarkers of disease activity in paediatric and adult ulcerative colitis. Methods: Paediatric (5-18 years) and adult (>18 years) patients scheduled for colonoscopy due to suspected or confirmed ulcerative colitis were included prospectively. Stool and blood samples were collected at time of colonoscopy and patient symptom scores were recorded. At colonoscopy the Ulcerative Colitis Endoscopic Index of Severity was recorded. Histology was graded according to the Geboes score. Results: 84 patients where included; 30 paediatric and ...
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
More News: Crohn's Disease | Gastroenterology | Incontinence | Inflammatory Bowel Disease | Internal Medicine | Sarcoidosis | Scleroderma | Skin | Vasculitis